How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency

Congenital factor XIII (FXIII) deficiency is an extremely rare bleeding disorder (RBD) with estimated prevalence of one per 2 million in the general population. The disorder causes different clinical manifestations such as intracranial hemorrhage (ICH), recurrent miscarriage, umbilical cord bleeding...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahraki, Hojat, Dorgalaleh, Akbar, Fathi, Majid, Tabibian, Shadi, Teimourian, Shahram, Mollanoori, Hasan, khiabani, Alireza, Zaker, Farhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876424/
https://www.ncbi.nlm.nih.gov/pubmed/33603988
http://dx.doi.org/10.18502/ijhoscr.v14i4.4480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876424/
https://www.ncbi.nlm.nih.gov/pubmed/33603988
http://dx.doi.org/10.18502/ijhoscr.v14i4.4480

Ejemplares similares